Abstract
The most significant datum presented in the paper by Judelson, et al (Pediatrics, 53:476, 1974) is that zoster immune globulin (ZIG) was made available to only a fraction of the children for whom it was requested. In the two years since these data were gathered, moreover, the supply of ZIG has not increased appreciably. This situation is particularly deplorable since the prognosis for children with leukemia, the major recipients of ZIG, is so much brighter.
- Copyright © 1974 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.